Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic

diabetes
Credit: CC0 Public Domain

Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic. The article describing these experiences and providing perspectives on the future application of tele-diabetes is published in Diabetes Technology & Therapeutics (DTT).

The article entitled "Managing New-Onset Type 1 Diabetes During COVID-19 Pandemic: Challenges and Opportunities" is coauthored by DTT Editor-in-Chief Satish Garg, University of Colorado (Aurora), David Rodbard, Biomedical Informatics Consultants LLC (Potomac, Maryland), Irl Hirsch, University of Washington (Seattle), and Gregory Forlenza, University of Colorado (Aurora).

The first patient was a 20-year-old who was treated in the hospital for a few days and then managed virtually. He was treated with multiple daily injections of insulin and a continuous glucose monitor, with data upload to his caregivers to facilitate virtual management of his . The physician adjusted his insulin dose every day. His initial time-in-range (TIR) was 16%, which improved to 58% after 2 weeks of virtual management, and at 3 weeks the TIR was at 90%.

The second patient was a 12-month-old who was started on an insulin pump and a continuous glucose monitor. The family was taught how to upload the insulin pump data via their home computer, using a software account linked to the hospital. The continuous glucose monitor was set up on a worn by the child on a fanny pack, with remote monitoring by both the parents and continuous connectivity to software linked to the hospital account. The physician made daily dose adjustments via phone or email based on the data received.

"The COVID-19 pandemic has forced many providers to look for alternative approaches to manage with new-onset type 1 diabetes through Telehealth, especially by employing new technologies like Dexcom G6 CGM and Clarity App. Since many of the long-standing regulations were removed during this pandemic along with similar reimbursements for Tele-visits, Telehealth, or Virtual patient visits, these have become a popular method of delivering care for both new-onset patients with type 1 diabetes and for established patients, with similar or even better outcomes," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver (Aurora).


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Satish K. Garg et al, Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities, Diabetes Technology & Therapeutics (2020). DOI: 10.1089/dia.2020.0161
Citation: Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic (2020, April 21) retrieved 14 July 2020 from https://medicalxpress.com/news/2020-04-tele-diabetes-new-onset-diabetes-covid-pandemic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments